Skip to main content
ABCL logo
ABCL
(NASDAQ)
AbCellera Biologics Inc.
$11.44-- (--)
Loading... - Market loading

AbCellera Biologics (ABCL) Stock Price & Financial Analysis

AbCellera Biologics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$11.10 - $11.64
52-Week High$12.58
52-Week Low$2.75
Open$11.29
Volume2.55M
Average Volume (3M)8.38M
Market Cap3.46B
Shares Outstanding303.07M
Price to Sales (P/S)43.74
Price to Book (P/B)3.69
EV/EBITDA-22.38
Revenue (TTM)79.21M
Net Income (TTM)-143.96M
Free Cash Flow (TTM)-189.23M
EPS (TTM)$-0.48
Profit Margin-181.75%
Operating Margin-259.50%
Return on Equity (ROE)-15.35%
Debt to Equity0.15
50-Day MA$8.50
200-Day MA$5.18
52-Week Change174.34%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About AbCellera Biologics

What is the current stock price for ABCL?

As of the latest trading session, ABCL stock trades at $11.44. The 52-week range is $2.75–$12.58, with a day range of $11.10–$11.64.

What is the P/E ratio for ABCL?

The P/E ratio (Price-to-Earnings) for ABCL is shown in the Key Statistics section. This valuation metric helps compare AbCellera Biologics Inc. to industry peers.

Does ABCL pay dividends?

AbCellera Biologics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ABCL?

Based on 17 analysts, the consensus for ABCL is Buy.

What is the market cap of ABCL?

AbCellera Biologics's market capitalization is $3.47B, classifying it as a mid-cap company. AbCellera Biologics operates in the Healthcare sector within the Biotechnology industry.